Pancreatic cancer remains one of the deadliest malignancies, with limited benefit from conventional immunotherapy. In 2025, several early-phase studies are testing personalized tumor vaccines—including mRNA-based,…
Tumor Vaccines for Pancreatic Cancer: Active and Recruiting Trials You Need to Know in 2025
